Regulatory Issues in Pain Management
This session will review the different types of regulatory policy and will include the Controlled Substance Act of 1970, FDA and REMS, State Regulations, and medico-legal issues and pain control.
Faculty: Bob Twillman, PhD
This 0.75 hour CME activity is designed for physicians, nurse practitioners and physician assistants as well as clinicians who treat chronic pain.
Upon completion of this activity, participants should be better able to:
- Delineate the four types of regulatory policy and provide an example of each.
- List the requirements under federal law for prescribing and dispensing controlled substances.
- Discuss the purposes and key characteristics of prescription drug monitoring programs (PDMPs).
- Describe the role of controlled substance agreements in the context of chronic pain management.
Bob Twillman, PhD, is the executive director for the American Academy of Pain Management. In that capacity, Dr. Twillman is responsible for overseeing federal and state pain policy developments and advocating for those supporting an integrative approach to managing pain. He also serves as Chair of the Prescription Monitoring Program Advisory Committee for the Kansas Board of Pharmacy. Dr. Twillman received his Ph.D. in Clinical Psychology at the University of California in Los Angeles, and maintains a volunteer faculty appointment as Clinical Associate Professor of Psychiatry and Behavioral Sciences at the University Of Kansas School Of Medicine in Kansas City, KS. Prior to taking his current position, Dr. Twillman was a full-time faculty member at the University of Kansas Medical Center, where he founded and directed the inpatient pain management program and was a co-founder of the hospital’s Palliative Care Team. He has been actively involved in pain policy through his work with the Alliance of State Pain Initiatives and the American Pain Society for many years.
Staff and Content Validation Reviewer Disclosures
The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.
Planning Committee/Faculty Disclosure
Dr. Twillman reports that he receives consultant and speaker fees from Janssen and Indivior.
Debra Nelson-Hogan, Director of Education for the Academy of Integrative Pain Management, reports that she has nothing to disclose.
Cathleen Coneghen, Assistant Director of Education for the Academy of Integrative Pain Management, reports that she has nothing to disclose.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a health care provider relative to diagnostic and treatment options of a specific patient’s medical condition.
For questions regarding CME for this activity, you may reach the department of education at the Academy of Integrative Pain Management at firstname.lastname@example.org.
For successful completion of this activity, please complete a pre-test; utilize the audio recordings synched with the presentation slides and videos to review the content, providing answers to your questions as necessary; and complete a post-test and evaluation following the activity. You will then be prompted to print your certificate. This activity should take approximately 45 minutes to complete.
This program is accredited for physicians, nurses, and psychologists. All other clinicians can submit the certificate of attendance upon completion of the program to their licensing boards for consideration of credit.
The American Academy of Pain Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Pain Management designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 0.75 AMA PRA Category 1 Credit(s)™
- 0.75 Document of Attendance